Published in N Engl J Med on September 16, 1999
Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation. Europace (2010) 1.47
Clinical impact of atrial fibrillation in patients with pulmonary hypertension. PLoS One (2012) 1.03
Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Heart (2005) 0.85
Prediction of atrial fibrillation development and progression: Current perspectives. World J Cardiol (2016) 0.80
Left atrial reverse remodeling in dogs with moderate and advanced heart failure treated with a passive mechanical containment device: an echocardiographic study. J Card Fail (2007) 0.77
Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial. Trials (2011) 0.77
Cardiac resynchronization therapy. Ochsner J (2009) 0.77
Atrial fibrillation in patients with heart failure: Role of catheter ablation therapies. Exp Clin Cardiol (2012) 0.76
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med (2001) 3.80
Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators. JAMA (2001) 3.38
The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol (2000) 2.99
Voluntary control of vascular tone by using skin-temperature biofeedback-relaxation in patients with advanced heart failure. Altern Ther Health Med (1997) 2.39
Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol (1997) 2.35
Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol (1995) 2.31
The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg (1999) 2.26
Team management of patients with heart failure: A statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart Association. Circulation (2000) 2.22
Low-dose amiodarone for atrial fibrillation: time for a prospective study? Ann Intern Med (1992) 2.14
Catheter ablation in patients with multiple and unstable ventricular tachycardias after myocardial infarction: short ablation lines guided by reentry circuit isthmuses and sinus rhythm mapping. Circulation (2001) 2.12
Atrial fibrillation after cardiac surgery. Ann Intern Med (2001) 2.10
Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J (2000) 1.94
The 6-min walk and peak oxygen consumption in advanced heart failure: aerobic capacity and survival. Am Heart J (1999) 1.94
Predicting prescribing costs in general practice using practice demography. Pharmacoepidemiol Drug Saf (1997) 1.93
Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant (2001) 1.92
Patterns of beat-to-beat heart rate variability in advanced heart failure. Am Heart J (1992) 1.91
Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J (1999) 1.90
Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia. J Am Coll Cardiol (1998) 1.85
Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. J Clin Invest (1988) 1.76
Mapping and radiofrequency catheter ablation of the three types of sustained monomorphic ventricular tachycardia in nonischemic heart disease. J Cardiovasc Electrophysiol (2000) 1.73
Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am J Cardiol (1998) 1.70
Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation (1991) 1.61
Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation (1989) 1.61
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale. Am Heart J (2001) 1.55
Ventricular arrhythmias in ischemic heart disease. Ann Intern Med (1991) 1.50
Quality of life in patients with advanced heart failure. J Heart Lung Transplant (1992) 1.47
Comparison of thermodilution and transthoracic electrical bioimpedance cardiac outputs. Heart Lung (1991) 1.47
Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation (1997) 1.46
Programmed electrical stimulation of the heart in patients with life-threatening ventricular arrhythmias: what is the significance of induced arrhythmias and what is the correct stimulation protocol? Circulation (1985) 1.43
Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol (1994) 1.40
Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol (1993) 1.39
Inotropic therapy for heart failure. N Engl J Med (1998) 1.39
Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol (1995) 1.29
Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol (2001) 1.26
Incidence and significance of early pericardial effusions after cardiac surgery. Am J Cardiol (1984) 1.26
Ventilatory and diffusion abnormalities in potential heart transplant recipients. Chest (1990) 1.25
Sudden death prevention in patients with advanced ventricular dysfunction. Circulation (1993) 1.23
Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. J Heart Lung Transplant (1999) 1.23
Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol (1993) 1.20
Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation. J Am Coll Cardiol (1994) 1.19
Timing of sudden death in patients with heart failure. J Am Coll Cardiol (1994) 1.19
Cardiac involvement in myotonic muscular dystrophy (Steinert's disease): a prospective study of 25 patients. Am J Cardiol (1984) 1.13
Recipient-to-donor atrioatrial conduction after orthotopic heart transplantation: surface electrocardiographic features and estimated prevalence. Am J Cardiol (1998) 1.12
Rupture of the Common Digital Extensor. Can J Comp Med Vet Sci (1942) 1.10
Catheter ablation of ventricular tachycardia after myocardial infarction: relation of endocardial sinus rhythm late potentials to the reentry circuit. J Am Coll Cardiol (1997) 1.07
Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (1989) 1.06
Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol (1990) 1.05
Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol (1996) 1.03
Multi atrial maco-re-entry circuits in adults with repaired congenital heart disease: entrainment mapping combined with three-dimensional electroanatomic mapping. J Am Coll Cardiol (2001) 1.02
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors. Am Heart J (2000) 1.02
Catheter ablation of ventricular tachycardia in patients with coronary heart disease: part I: Mapping. Pacing Clin Electrophysiol (2001) 1.02
Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial. J Am Coll Cardiol (1992) 1.02
24th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization. J Am Coll Cardiol (1993) 1.01
Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure. Circulation (1986) 1.01
Reversal of ischemic myocardial dysfunction by PTCA in a cardiac transplant patient. Am Heart J (1986) 1.00
Heart transplantation in a Jehovah's Witness. J Heart Transplant (1987) 1.00
Sexual function in patients with advanced heart failure. Heart Lung (1996) 1.00
Prognosis after syncope: impact of left ventricular function. Am Heart J (1993) 0.99
Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study. J Am Coll Cardiol (1986) 0.98
Catheter ablation of ventricular tachycardia in patients with coronary heart disease. Part II: Clinical aspects, limitations, and recent developments. Pacing Clin Electrophysiol (2001) 0.97
Complex heart rate variability and serum norepinephrine levels in patients with advanced heart failure. J Am Coll Cardiol (1994) 0.97
Predictability of mitral regurgitation detected by Doppler echocardiography in patients referred for cardiac transplantation. Am J Cardiol (1987) 0.97
Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital. Ann Intern Med (1997) 0.97
Characteristics of electrograms recorded at reentry circuit sites and bystanders during ventricular tachycardia after myocardial infarction. J Am Coll Cardiol (1999) 0.96
Proarrhythmia. Am J Cardiol (1998) 0.96
Increased risk of progressive hemodynamic deterioration in advanced heart failure patients requiring permanent pacemakers. Am Heart J (1993) 0.96
Beta-adrenergic blockers and survival in heart failure. N Engl J Med (1996) 0.94
Energy and protein nutrition of early-weaned pigs. 1. Effect of energy intake and energy: protein on growth, efficiency and nitrogen utilization of pigs between 8-32 d. Br J Nutr (1980) 0.93
Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (1993) 0.93
Catheter ablation for hemodynamically unstable monomorphic ventricular tachycardia. J Cardiovasc Electrophysiol (2000) 0.92
Increasing catheter ablation lesion size by simultaneous application of radiofrequency current to two adjacent sites. Am Heart J (1993) 0.92
Histologic evolution of radiofrequency lesions in an old human myocardial infarct causing ventricular tachycardia. J Cardiovasc Electrophysiol (1995) 0.91
The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size. J Am Coll Cardiol (1998) 0.91
Independent control of skin and muscle sympathetic nerve activity in patients with heart failure. Circulation (1994) 0.90
Clinical, angiographic, and electrophysiologic findings in patients with aborted sudden death as compared with patients with sustained ventricular tachycardia after myocardial infarction. Circulation (1985) 0.90
Ventricular mapping during atrial and ventricular pacing. Relationship of multipotential electrograms to ventricular tachycardia reentry circuits after myocardial infarction. Eur Heart J (2002) 0.90
Amiodarone therapy does not compromise subsequent heart transplantation. J Am Coll Cardiol (1992) 0.90
Amiodarone and post-MI patients. Circulation (1993) 0.89
Extended comparison of quality of life between stable heart failure patients and heart transplant recipients. J Heart Lung Transplant (1995) 0.89
Narrow QRS ventricular tachycardia. Am Heart J (1986) 0.88
Excessive oxygen deficit during low-level exercise in heart failure. Am J Cardiol (1995) 0.88
Electrophysiology and anatomic characterization of an epicardial accessory pathway. J Cardiovasc Electrophysiol (2001) 0.87
Anatomic and electrophysiologic relation between the coronary sinus and mitral annulus: implications for ablation of left-sided accessory pathways. Am Heart J (1998) 0.87
Preferential locations for critical reentry circuit sites causing ventricular tachycardia after inferior wall myocardial infarction. J Cardiovasc Electrophysiol (1997) 0.86
Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation. Circulation (1991) 0.85
Prevention of sudden death in heart failure. J Cardiovasc Electrophysiol (2001) 0.85
Single catheter determination of local electrogram prematurity using simultaneous unipolar and bipolar recordings to replace the surface ECG as a timing reference. Pacing Clin Electrophysiol (2001) 0.84
Programmed electrical stimulation: its role in the management of ventricular arrhythmias in coronary heart disease. Prog Cardiovasc Dis (1987) 0.84
Mechanical cardiac support 2000: current applications and future trial design. June 15-16, 2000 Bethesda, Maryland. J Am Coll Cardiol (2001) 0.84